Highly Targeted Cancer Treatment Proves “Stunningly Successful”
Chemotherapy has become increasingly effective in slowing and stopping many cancers, but it is still mainly a broad-brush approach, filling the patient’s body with harmful chemicals to kill only a few cancerous cells. Researchers have been working for decades to develop the next generation of cancer drugs that are much more highly targeted at only the cancerous cells.
A new study, presented at the annual meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine, showed that patients with metastatic breast cancer treated with a new drug called Enhertu that targeted cancer cells with laser-like precision was stunningly successful, slowing tumor growth and extending life to an extent rarely seen with advanced cancers.
The results were so impressive that the researchers received a standing ovation when they presented their data at the oncology conference.
